Literature DB >> 2180500

Karyotype and in vitro-response to GM-CSF. Analysis of bone marrow cultures in leukemia, myelodysplasia and aplastic anemia.

D Haase1, C Fonatsch.   

Abstract

The influence of GM-CSF on bone marrow cultures from 13 patients with aplastic anemia, MDS and acute leukemia was studied in a short-term suspension culture system. In each case combined cytogenetic and proliferation analyses were performed with respect to the question, whether chromosome aberrations play a role in the in vitro response to GM-CSF and in order to search for stimulating effects on malignant cells. The responsiveness was compared of aplastic and myelodysplastic cultures on the one hand and of leukemic cells on the other. Our results show that myelodysplastic and aplastic cells display a tendency for reduced susceptibility to GM-CSF as compared to healthy controls, while in leukemic bone marrow the response to the growth factor was significantly enhanced, indicating a leukemia-specific response pattern. In the majority of leukemias analyzed, the presence of cytogenetically abnormal cells in cultures with excessive response to GM-CSF can be taken as a proof for stimulation of malignant cells. The significance of these findings for pathogenesis and prognosis in aplastic anemia, myelodysplasia and leukemia is discussed.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2180500     DOI: 10.1007/BF01720275

Source DB:  PubMed          Journal:  Blut        ISSN: 0006-5242


  24 in total

1.  Effect of low-level, 60-Hz electromagnetic fields on human lymphoid cells: I. Mitotic rate and chromosome breakage in human peripheral lymphocytes.

Authors:  M M Cohen; A Kunska; J A Astemborski; D McCulloch; D A Paskewitz
Journal:  Bioelectromagnetics       Date:  1986       Impact factor: 2.010

2.  Potentiation of growth factor activity by exogenous c-myc expression.

Authors:  V Sorrentino; V Drozdoff; M D McKinney; L Zeitz; E Fleissner
Journal:  Proc Natl Acad Sci U S A       Date:  1986-11       Impact factor: 11.205

3.  Demonstration of burst-promoting activity of recombinant human GM-CSF on circulating erythroid progenitors using an assay involving the delayed addition of erythropoietin.

Authors:  R E Donahue; S G Emerson; E A Wang; G G Wong; S C Clark; D G Nathan
Journal:  Blood       Date:  1985-12       Impact factor: 22.113

4.  Human GM-CSF primes neutrophils for enhanced oxidative metabolism in response to the major physiological chemoattractants.

Authors:  R H Weisbart; L Kwan; D W Golde; J C Gasson
Journal:  Blood       Date:  1987-01       Impact factor: 22.113

5.  Phase I/II study of recombinant human granulocyte-macrophage colony-stimulating factor in aplastic anemia and myelodysplastic syndrome.

Authors:  J H Antin; B R Smith; W Holmes; D S Rosenthal
Journal:  Blood       Date:  1988-08       Impact factor: 22.113

6.  Human granulocyte-macrophage colony-stimulating factor is a growth factor active on a variety of cell types of nonhemopoietic origin.

Authors:  S Dedhar; L Gaboury; P Galloway; C Eaves
Journal:  Proc Natl Acad Sci U S A       Date:  1988-12       Impact factor: 11.205

Review 7.  The 5q-anomaly.

Authors:  H Van den Berghe; K Vermaelen; C Mecucci; D Barbieri; G Tricot
Journal:  Cancer Genet Cytogenet       Date:  1985-07

8.  Clonal analysis of the action of GM-CSF on the proliferation and differentiation of myelomonocytic leukemic cells.

Authors:  D Metcalf
Journal:  Int J Cancer       Date:  1979-11-15       Impact factor: 7.396

9.  Biologic properties in vitro of a recombinant human granulocyte-macrophage colony-stimulating factor.

Authors:  D Metcalf; C G Begley; G R Johnson; N A Nicola; M A Vadas; A F Lopez; D J Williamson; G G Wong; S C Clark; E A Wang
Journal:  Blood       Date:  1986-01       Impact factor: 22.113

10.  Synergism between recombinant growth factors, GM-CSF and G-CSF, acting on the blast cells of acute myeloblastic leukemia.

Authors:  C Kelleher; J Miyauchi; G Wong; S Clark; M D Minden; E A McCulloch
Journal:  Blood       Date:  1987-05       Impact factor: 22.113

View more
  3 in total

1.  Monosomy 7 provides a proliferative advantage for leukemic cells under incubation with GM-CSF in vitro.

Authors:  D Haase; C Fonatsch
Journal:  Blut       Date:  1990-11

2.  Recombinant Granulocyte-Macrophage Colony-Stimulating Factor (rGM-CSF) : A Review of its Pharmacological Properties and Prospective Role in the Management of Myelosuppression.

Authors:  Susan M Grant; Rennie C Heel
Journal:  Drugs       Date:  1992-04       Impact factor: 9.546

3.  Cytogenetic findings in 179 patients with myelodysplastic syndromes.

Authors:  D Haase; C Fonatsch; M Freund; B Wörmann; H Bodenstein; H Bartels; B Stollmann-Gibbels; E Lengfelder
Journal:  Ann Hematol       Date:  1995-04       Impact factor: 3.673

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.